These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18927305)
1. Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Couvelard A; Deschamps L; Rebours V; Sauvanet A; Gatter K; Pezzella F; Ruszniewski P; Bedossa P Clin Cancer Res; 2008 Oct; 14(20):6634-9. PubMed ID: 18927305 [TBL] [Abstract][Full Text] [Related]
2. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Soilleux EJ; Turley H; Tian YM; Pugh CW; Gatter KC; Harris AL Histopathology; 2005 Dec; 47(6):602-10. PubMed ID: 16324198 [TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863 [TBL] [Abstract][Full Text] [Related]
4. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060 [TBL] [Abstract][Full Text] [Related]
5. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195 [TBL] [Abstract][Full Text] [Related]
6. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Giatromanolaki A; Koukourakis MI; Pezzella F; Turley H; Sivridis E; Bouros D; Bougioukas G; Harris AL; Gatter KC Cancer Lett; 2008 Apr; 262(1):87-93. PubMed ID: 18187257 [TBL] [Abstract][Full Text] [Related]
7. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors. Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832 [TBL] [Abstract][Full Text] [Related]
8. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310 [TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356 [TBL] [Abstract][Full Text] [Related]
10. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer. Gossage L; Zaitoun A; Fareed KR; Turley H; Aloysius M; Lobo DN; Harris AL; Madhusudan S Histopathology; 2010 Jun; 56(7):908-20. PubMed ID: 20497244 [TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy. Prabhu V; Guruvayoorappan C Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):568-75. PubMed ID: 21226555 [TBL] [Abstract][Full Text] [Related]
12. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma. Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905 [TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart. Rohrbach S; Simm A; Pregla R; Franke C; Katschinski DM Biogerontology; 2005; 6(3):165-71. PubMed ID: 16041620 [TBL] [Abstract][Full Text] [Related]
15. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. Willam C; Nicholls LG; Ratcliffe PJ; Pugh CW; Maxwell PH Adv Enzyme Regul; 2004; 44():75-92. PubMed ID: 15581484 [No Abstract] [Full Text] [Related]
16. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer. Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862 [TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites. Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436 [TBL] [Abstract][Full Text] [Related]
18. Gene regulation in response to graded hypoxia: the non-redundant roles of the oxygen sensors PHD and FIH in the HIF pathway. Dayan F; Monticelli M; Pouysségur J; Pécou E J Theor Biol; 2009 Jul; 259(2):304-16. PubMed ID: 19298827 [TBL] [Abstract][Full Text] [Related]